193 related articles for article (PubMed ID: 34986863)
21. Detrimental effects of endometriosis on oocyte morphology in intracytoplasmic sperm injection cycles: a retrospective cohort study.
Kasapoglu I; Kuspinar G; Saribal S; Turk P; Avcı B; Uncu G
Gynecol Endocrinol; 2018 Mar; 34(3):206-211. PubMed ID: 29057690
[TBL] [Abstract][Full Text] [Related]
22. [Oocyte and embryo quality in polycystic ovary syndrome].
Plachot M; Belaisch-Allart J; Mayenga JM; Chouraqui A; Tesquier A; Serkine AM; Boujenah A; Abirached F
Gynecol Obstet Fertil; 2003 Apr; 31(4):350-4. PubMed ID: 12821065
[TBL] [Abstract][Full Text] [Related]
23. Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care.
Tannus S; Tan J; Son WY; Dahan MH
Arch Gynecol Obstet; 2018 Apr; 297(4):1037-1042. PubMed ID: 29289990
[TBL] [Abstract][Full Text] [Related]
24. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
25. IVF versus ICSI for the fertilization of in-vitro matured human oocytes.
Walls M; Junk S; Ryan JP; Hart R
Reprod Biomed Online; 2012 Dec; 25(6):603-7. PubMed ID: 23063820
[TBL] [Abstract][Full Text] [Related]
26. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
[No Abstract] [Full Text] [Related]
27. [Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory].
Kdous M; Chaker A; Zhioua A; Zhioua F
J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):133-43. PubMed ID: 19179017
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Anti-müllerian Hormone (AMH) and Hormonal Assays for Phenotypic Classification of Polycystic Ovary Syndrome.
Ozay AC; Emekcı Ozay O; Gulekli B
Ginekol Pol; 2020; 91(11):661-667. PubMed ID: 33301159
[TBL] [Abstract][Full Text] [Related]
29. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
[TBL] [Abstract][Full Text] [Related]
30. May AMH levels distinguish LOCAH from PCOS among hirsute women?
Oncul M; Sahmay S; Tuten A; Acikgoz AS; Gurleyen HC
Eur J Obstet Gynecol Reprod Biol; 2014 Jul; 178():183-7. PubMed ID: 24792539
[TBL] [Abstract][Full Text] [Related]
31. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of Adolescents with Differing Polycystic Ovary Syndrome Phenotypes.
Fitzgerald S; Stamoulis C; Gooding HC; DiVasta AD
J Pediatr Adolesc Gynecol; 2020 Dec; 33(6):697-702. PubMed ID: 32889085
[TBL] [Abstract][Full Text] [Related]
33. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
[TBL] [Abstract][Full Text] [Related]
34. Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters.
De Vos M; Pareyn S; Drakopoulos P; Raimundo JM; Anckaert E; Santos-Ribeiro S; Polyzos NP; Tournaye H; Blockeel C
Reprod Biomed Online; 2018 Aug; 37(2):163-171. PubMed ID: 29778554
[TBL] [Abstract][Full Text] [Related]
35. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis.
Lizneva D; Kirubakaran R; Mykhalchenko K; Suturina L; Chernukha G; Diamond MP; Azziz R
Fertil Steril; 2016 Nov; 106(6):1510-1520.e2. PubMed ID: 27530062
[TBL] [Abstract][Full Text] [Related]
36. Follicular fluid redox balance and DNA damage according to PCOS phenotype.
Onal M; Agar M
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5583-5589. PubMed ID: 37401295
[TBL] [Abstract][Full Text] [Related]
37. DIAGNOSTIC VALUE OF ANTI-MÜLLERIAN HORMONE AS A BIOMARKER FOR POLYCYSTIC OVARY SYNDROME: A META-ANALYSIS UPDATE.
Zhao Y; Zhao Y; Wang C; Liang Z; Liu X
Endocr Pract; 2019 Oct; 25(10):1056-1066. PubMed ID: 31414908
[No Abstract] [Full Text] [Related]
38. Use of gonadotropin-releasing hormone agonist trigger during in vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndrome.
O'Neill KE; Senapati S; Dokras A
Fertil Steril; 2015 Jan; 103(1):264-9. PubMed ID: 25450300
[TBL] [Abstract][Full Text] [Related]
39. IVF versus ICSI in sibling oocytes from patients with polycystic ovarian syndrome: a randomized controlled trial.
Hwang JL; Seow KM; Lin YH; Hsieh BC; Huang LW; Chen HJ; Huang SC; Chen CY; Chen PH; Tzeng CR
Hum Reprod; 2005 May; 20(5):1261-5. PubMed ID: 15705619
[TBL] [Abstract][Full Text] [Related]
40. Impact of body mass index on intracytoplasmic sperm injection in women with polycystic ovary syndrome.
Kamardi S; Surya IHW; Mahendra INB; Adnyana IP; Suardika A; Tondohusodo N; Sudiman J
Zygote; 2021 Jun; 29(3):229-233. PubMed ID: 33455589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
